SCHEMBL24470239

SCHEMBL24470239

O=P(c1ccccc1)(c1ccccc1)c1ccc2oc3ccccc3c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
KDM4E B2RXH2 4/20 0.49
ALDH1A1 P00352 3/20 0.49
HPGD P15428 3/20 0.49
MEN1 O00255 3/20 0.49
RAB9A P51151 3/20 0.49
KMT2A Q03164 3/20 0.49
NPC1 O15118 3/20 0.49
AHR P35869 2/20 0.44
LMNA P02545 1/20 0.44
MAOA P21397 3/20 0.42
GLA P06280 1/20 0.42
CYP3A4 P08684 1/20 0.42
PGAM1 P18669 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
HSD17B10 Q99714 1/20 0.42
BCAT1 P54687 1/20 0.42
TTR P02766 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9927330 0.95 MAPT (0.53) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL29350480 0.95 KDM4E (0.42) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL9927366 0.95 KDM4E (0.42) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL16440658 0.94 PLA2G2A (0.48) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL16440646 0.94 PLA2G2A (0.48) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL16440675 0.90 PLA2G2A (0.50) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL16440829 0.90 PLA2G2A (0.50) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL17614153 0.90 AHR (0.49) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL9099105 0.90 AHR (0.49) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL18372037 0.90 MAPT (0.49) MAPTSMN1; SMN2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230284524-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-07 US disclosed
US-20230284524-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-07 US disclosed
US-20220190296-A1 LIGHT-EMITTING DEVICE AND AN ELECTRONIC DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-06-16 US disclosed
US-20220173331-A1 LIGHT-EMITTING DEVICE AND AN ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230284524-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME EML4, SLC1A2, EMD MAPT 2628/4885SMN1; SMN2 4008/4885KDM4E 1756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.